FIELD: organic chemistry.
SUBSTANCE: group of inventions includes a compound of formula [I], its pharmaceutically acceptable salt, use, a pharmaceutical composition containing it, a method of inhibiting SGLT1 and a method of treating diabetes.
EFFECT: compound of formula [I] with SGLT1-inhibiting activity used for the treatment of diabetes.
11 cl, 2 dwg, 7 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRAZOLE COMPOUNDS SUBSTITUTED BY HETEROARYL AND THEIR APPLICATION IN PHARMACEUTICS | 2019 |
|
RU2805312C2 |
| PYRAZOLE COMPOUND AND ITS PHARMACEUTICAL USE | 2012 |
|
RU2617678C2 |
| C-PHENYL GLYCITOL COMPOUND FOR TREATING DIABETES | 2007 |
|
RU2437876C2 |
| C-PHENYL-1-THIOGLUCITOLS | 2007 |
|
RU2434862C2 |
| 4-ISOPROPYLPHENYLGLUCITE DERIVATIVES AS SGLT1 INHIBITORS | 2010 |
|
RU2518896C2 |
| SPIROKETAL DERIVATIVES AND USE THEREOF AS MEDICINAL AGENT AGAINST DIABETES | 2006 |
|
RU2416617C2 |
| CONDENSED HETEROCYCLIC DERIVATIVES MEDICAL COMPOSITIONS CONTAINING THEM AND THEIR MEDICAL APPLICATION | 2005 |
|
RU2387663C2 |
| PYRAZOL DERIVATIVES, MEDICAL COMPOSITIONS, CONTAINING THEM, THEIR APPLICATION IN MEDICINE AND INTERMEDIATE COMPOUNDS FOR THEIR PRODUCTION | 2003 |
|
RU2369613C2 |
| PYRAZOLE-AMIDE COMPOUND AND MEDICINAL USES THEREFOR | 2014 |
|
RU2664532C2 |
| NEW GLUCITOL DERIVATIVE, PRODRUG AND SALT AND THERAPEUTIC AGENT CONTAINING THEM FOR DIABETES TREATMENT | 2005 |
|
RU2386631C2 |
